Testing effectiveness (Phase 2)Study completedNCT06500429
What this trial is testing
Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
Who this might be right for
Overweight and ObesityHealthy
Neurogastrx, Inc. 120